Upper 49th Unit 2 2715 Bristol Circle Oakville, Ontario L6H 6X5
Marketing Authorization Holder
N/A
Capsule
N/A
375mg / Capsule
Reason
Yohimbine and its salts and derivatives are described in Schedule F, Part I of the Food and Drugs Regulations. The presence of the substance in an unapproved drug product represents an unacceptable risk to health.